About Impulse Monitoring
Impulse Monitoring is a Healthcare company based in Columbia (United States) founded in 2002, and was acquired by NuVasive in September 2011. Intraoperative neurophysiological monitoring is conducted for spinal and brain surgeries. Impulse Monitoring has raised $13.5 million across 2 funding rounds from investors including NuVasive and Tullis Health Investors. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Impulse Monitoring, Inc. Its competitors include Q’Apel Medical, Zeta Surgical and InNeuroCo; 3 of its 3 listed competitors have raised funding.
Company details
Impulse Monitoring was founded in 2002 in Columbia, United States, within the healthcare sector focused on neurophysiological services. Onsite and web-based systems are utilized to monitor neurological functions during spinal and brain surgeries. Electrophysiological and vascular techniques are employed to provide early warnings of potential issues. The company was acquired by NuVasive in 2011, integrating its operations into broader medical technology offerings.
- Headquarters Columbia, United States
- Stage Acquired
- SectorsHealthcare
- Website impulsemonitoring.com
- Social LinkedIn
- Acquired by NuVasive (Sep 2011)
- Legal Name Impulse Monitoring, Inc
Funding Insights of Impulse Monitoring
Impulse Monitoring has successfully raised a total of $13.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.5 million completed in February 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.5M
- Total Rounds 2
- Last Round Series A — $4.5M
- First Round $9M
(Jun 2006)
- Investors Count 1
All 2 funding rounds of Impulse Monitoring with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2007 | $4.5M | Series A | – | – | |
| Jun 2006 | $9M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Impulse Monitoring
Impulse Monitoring has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NuVasive and Tullis Health Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments are made by Tullis Health Investors. | tullisfunds.com | Palm Beach Gardens, United States | ||
Smart surgical devices for spinal surgery are developed. | 1997 | nuvasive.com | San Diego, United States |
Investor details for Impulse Monitoring
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Impulse Monitoring
4 dated milestones of Impulse Monitoring across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Impulse Monitoring is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series A, of $4.5M.
- Exit Acquired by NuVasive.
Competitors of Impulse Monitoring
Impulse Monitoring has 3 listed competitors in our database, 3 of them funded. They include Q’Apel Medical, Zeta Surgical and InNeuroCo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| qapelmedical.com | 2019 | Fremont, United States | $51.9M | 100 | Medical devices for neurovascular disorder treatments are provided. | |
| zetasurgical.com | 2016 | Boston, United States | $8.16M | 7 | AI-based navigation and robotics systems for surgeries are developed. | |
| inneuroco.com | 2014 | Sunrise, United States | $1.51M | 99 | Intermediate catheters and super distal access device for neurovascular surgery |
Detailed competitors of Impulse Monitoring
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Impulse Monitoring (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Impulse Monitoring
Complete news archive for Impulse Monitoring
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impulse Monitoring
Impulse Monitoring was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Impulse Monitoring is headquartered in Columbia, United States.
Impulse Monitoring is a funded company, having raised a total of $13.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9M, raised on Jun 2006.
Impulse Monitoring was founded in 2002 in Columbia, United States, within the healthcare sector focused on neurophysiological services. Onsite and web-based systems are utilized to monitor neurological functions during spinal and brain surgeries. Electrophysiological and vascular techniques are employed to provide early warnings of potential issues. The company was acquired by NuVasive in 2011, integrating its operations into broader medical technology offerings.
Impulse Monitoring's top competitors include Zeta Surgical, Q’Apel Medical and InNeuroCo.
Impulse Monitoring has 2 investors. Key investors include NuVasive, and Tullis Health Investors.
Impulse Monitoring operates through Impulse Monitoring, Inc.
Yes. Impulse Monitoring was acquired by NuVasive in September 2011.